Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine
Idiopathic pulmonary fibrosis (IPF) is a chronic, rare progressive lung disease, characterized by lung scarring and the irreversible loss of lung function. Two anti-fibrotic drugs, nintedanib and pirfenidone, have been demonstrated to slow down disease progression, although IPF mortality remains a c...
Main Authors: | Aitana Alonso-Gonzalez, Eva Tosco-Herrera, Maria Molina-Molina, Carlos Flores |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1152211/full |
Similar Items
-
Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
by: Sofía Tesolato, et al.
Published: (2023-12-01) -
Idiopathic Pulmonary Fibrosis and Telomeres
by: Alba Mulet, et al.
Published: (2022-11-01) -
Genetic association of telomere length, obesity and tobacoo smoking with idiopathic pulmonary fibrosis risk
by: Wenjuan Wu, et al.
Published: (2023-05-01) -
Precision medicine advances in idiopathic pulmonary fibrosis
by: Theodoros Karampitsakos, et al.
Published: (2023-09-01) -
Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)